An Open-Label Multicentre Long-Term Extension Study of Etanercept for Ankylosing Spondylitis

NCT00444340 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Ankylosing Spondylitis

Interventions

DRUG: Enbrel (Etanercept)

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer